✦ LIBER ✦

In reference to Tacrolimus: A new option in therapy-resistant chronic external otitis

✍ Scribed by Paul Lennon; John Fenton

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 36 KB
Volume: 120
Category: Article
ISSN: 0023-852X
DOI: 10.1002/lary.20904

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In response to Tacrolimus: A new option

In response to Tacrolimus: A new option in therapy-resistant chronic external otitis

✍ Philipp P. Caffier; Heidemarie Haupt; Benedikt Sedlmaier; Wolfgang Harth 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

Matrix therapy in regenerative medicine,

Matrix therapy in regenerative medicine, a new approach to chronic wound healing

✍ V. Barbier-Chassefière; S. Garcia-Filipe; X. L. Yue; M. E. Kerros; E. Petit; P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

## Abstract Nonhealing wounds remain a major health problem whose treatment is challenging and costly. Treatments based on cells or growth factors are still not very effective. We developed an entirely novel strategy consisting in treatment of the wound‐tissue matrix with biopolymers engineered to

Pilot study of lonafarnib, a farnesyl tr

Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy

✍ Gautam Borthakur; Hagop Kantarjian; George Daley; Moshe Talpaz; Susan O'Brien; G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Interferon alfa-2c in chronic myelogenou

Interferon alfa-2c in chronic myelogenous leukemia (CML): Hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma

✍ Herrmann, F. ;Jonas, D. ;Helfrich, S. G. ;Lindemann, A. ;Schleiermacher, E. ;Mer 📂 Article 📅 1990 🏛 Springer-Verlag ⚖ 849 KB

Long-lasting response of therapy-resista

Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiency

✍ Terry J. Hamblin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

High-dose azathioprine pulse therapy as

High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener’s granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide

✍ E. Benenson; J. W. U. Fries; B. Heilig; M. Pollok; A. Rubbert 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 371 KB